Form 4 for TRAW Traws Pharma, Inc.
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-13 · accession 0001415889-24-008142 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-15 | 2024-03-13 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | — | +8,666 | 38.6K | +29% | — |
| D | 2024-03-15 | 2024-03-14 | TRAW | Guerin Mark Patrick | CFO AND COO | F - Tax | $0.9 | -2,591 | 36.0K | -7% | -$2,332 |
| D | 2024-03-15 | 2024-03-13 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | $0.00 | -8,666 | 17.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-13 | M | A | 8,666 | — | 38,567 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-03-14 | F | D | 2,591 | $0.9 | 35,976 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-03-13 | M | D | 8,666 | $0.00 | 17,334 | D | — · — to — | 8,666 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On March 13, 2023 the reporting person was granted 26,000 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. |